About Aaron Missere
Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.
Recent Articles By Aaron Missere
Why are Shares of Tilray (TLRY) Up Over 30% in the Past Week?
Over the last week, shares of Tilray Inc. (TLRY) have jumped more than 30% from a 52-week low of $15.01, to over $20.
Why is OrganiGram (OGI) Surging 46% Today?
Shares of OrganiGram (OGI) are on fire today, up 46%, after the company reported fiscal first-quarter revenue that doubled, crushing Wall Street estimates.
Why Did Shares of Aurora Cannabis Trade to a 52-week Low Today?
Shares of Aurora Cannabis (ACB) have been getting crushed recently as more and more downgrades have hit the company.
What to Expect From Aphria's (APHA) Upcoming Earnings Report
While most other stocks in the cannabis industry have been reporting losses each quarter, Aphria Inc. (APHA) has bucked the trend.
CannTrust: A High Risk/Reward Investment
At its highest level back in 2019, the CannTrust’s stock soared to above $10 per share. After the fallout, the stock crashed to $0.75.
Why is Aurora Cannabis Selling One of its Greenhouses?
This week Aurora Cannabis announced that they would be selling one of their largest greenhouses.
Where are Shares of Cronos Group Headed in 2020?
Last week we saw cannabis stocks skyrocket on the last day of trading and many are wondering if this will be the start of a huge rally for the sector.
What are Analysts Predicting for Shares of GW Pharmaceuticals in 2020
There are a total of 15 analysts that cover GW Pharmaceuticals as of December 24, 2019. Of those analysts 5 rate the company a “strong-buy,” and 10 rate it as a “buy.”
Where are Shares of HEXO headed in 2020?
2019 was an extremely tough year for HEXO shareholders. The stock saw highs in April of over $8 only to see it trade currently under $2.